| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/11/2005 | EP1004308B1 Preventives or remedies for drug-induced renal disturbance |
| 05/11/2005 | EP1001771B1 A medicament against endometriosis-associated infertility |
| 05/11/2005 | EP0986408B1 New medicaments based on polymers composed of methacrylamide-modified gelatin |
| 05/11/2005 | EP0971898B1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 05/11/2005 | EP0969815B1 Pharmaceutical compositions |
| 05/11/2005 | EP0951464B1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/11/2005 | EP0942716B1 Composition for transdermal delivery of drugs |
| 05/11/2005 | EP0861071B1 Benzamidoxime prodrugs and use thereof for treating pneumonia |
| 05/11/2005 | EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins |
| 05/11/2005 | EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 05/11/2005 | CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor |
| 05/11/2005 | CN1615368A Effectors of innate immunity |
| 05/11/2005 | CN1615309A Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 05/11/2005 | CN1615308A Prucalopride-N-oxide |
| 05/11/2005 | CN1615307A Process and intermediates for pyridazinone antidiabetic agents |
| 05/11/2005 | CN1615306A C-5 modified indazolylpyrrolotriazines |
| 05/11/2005 | CN1615305A Coumarin derivatives, process for their production and use thereof |
| 05/11/2005 | CN1615301A Dithiocarbamate derivatives and their use as antibacterial agents |
| 05/11/2005 | CN1615300A Benzimidazole derivatives and their use as GNRH antagonists |
| 05/11/2005 | CN1615297A Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 05/11/2005 | CN1615296A Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 05/11/2005 | CN1615159A Preparation for wound healing and prevention of bandage adhesion to the wound |
| 05/11/2005 | CN1615157A Compositions inhibiting rejection in organ transplantation and method of using the same |
| 05/11/2005 | CN1615156A Preparation of resinates |
| 05/11/2005 | CN1615155A Anti-proliferative composition |
| 05/11/2005 | CN1615153A Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug |
| 05/11/2005 | CN1615152A Method for reducing acne or improving skin tone |
| 05/11/2005 | CN1615150A Assay for the detection of factors that modulate the expression of INGAP |
| 05/11/2005 | CN1615147A Treatment of glioblastoma with thymosin-alpha 1 |
| 05/11/2005 | CN1615146A 生姜提取物制剂 Ginger extract preparation |
| 05/11/2005 | CN1615145A Lower alcohol-insoluble extract of hovenia dulcis thunb and a polysaccharide isolated therefrom |
| 05/11/2005 | CN1615144A A composition for treating neurocerebrovascular disorders |
| 05/11/2005 | CN1615141A Use of polysaccharide derivatives as anti-infective substances |
| 05/11/2005 | CN1615139A 25-hydroxy vitamin D3 compositions |
| 05/11/2005 | CN1615138A Melanogenesis inhibitors and whitening agents comprising ergosterol derivatives and compositions containing ergosterol derivatives |
| 05/11/2005 | CN1615137A Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof |
| 05/11/2005 | CN1615136A Combinations comprising epothilones and anti-metabolites |
| 05/11/2005 | CN1615135A Oral dosage form of a sulfonamide prodrug such as parecoxib |
| 05/11/2005 | CN1615134A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 05/11/2005 | CN1615133A Crystalline solids of carvedilol and processes for their preparation |
| 05/11/2005 | CN1615132A Melanogenesis inhibitors and whitening agents comprising egonol derivatives and compositions containing egonol derivatives |
| 05/11/2005 | CN1615131A Method for identification of tumor targeting enzymes |
| 05/11/2005 | CN1615130A Taxane based compositions and methods of use |
| 05/11/2005 | CN1615129A Process for affecting neurologic progression |
| 05/11/2005 | CN1615128A Preparation for improving the action of receptors |
| 05/11/2005 | CN1615127A Substituted bicyclo[3.3.1]nonan-2, 4, 9-triones as pharmaceutical active ingredients |
| 05/11/2005 | CN1615124A Formulations |
| 05/11/2005 | CN1615123A Bilayer pharmaceutical tablets comprising telmisartan and diuretic and their preparation |
| 05/11/2005 | CN1615122A Pharmaceutical formulation comprising bicalutamide |
| 05/11/2005 | CN1615106A Method and process for producing youthful-appearing, small-pored, and smooth skin |
| 05/11/2005 | CN1613876A Three spiral lentinan with anti-cancer activity and its preparation and use |
| 05/11/2005 | CN1613868A Conjugate of hydrophilic polymer-fustic extract and medicinal composition |
| 05/11/2005 | CN1613867A Antineoplastic comound, Preparation and medicine composition with compound as active ingredient |
| 05/11/2005 | CN1613865A Trans-oligonucleotide, medicinal composition containing it and use thereof |
| 05/11/2005 | CN1613862A Adriacin derivative with anti-cancer activity |
| 05/11/2005 | CN1613858A Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 05/11/2005 | CN1613853A PDF enzyme inhibitor-hydroxamic acid serial compounds synthetic method and use thereof |
| 05/11/2005 | CN1613503A Technology for producing viral vaccine in biological reactor |
| 05/11/2005 | CN1613453A Azithromycin injection and its preparation |
| 05/11/2005 | CN1613452A Colon-released preparation of Melocicon and beta-cyclodextrin or its derivative composition |
| 05/11/2005 | CN1613451A Powder injection of lactatelevo-ofloxacin and its preparation |
| 05/11/2005 | CN1613450A Use of sedenafin |
| 05/11/2005 | CN1613449A Injections containing Fuliconzone and their preparation |
| 05/11/2005 | CN1613448A Oral disintegrated and/or oral soluble solid hydrocyclo-benzenenonate |
| 05/11/2005 | CN1613447A Sustained released enteric soluble medicines |
| 05/11/2005 | CN1613446A Sustained released malotilate preparation for hepa titis and cirrhosis |
| 05/11/2005 | CN1613445A Luteolin, its derivative and use for inhibiting enterocinesia |
| 05/11/2005 | CN1613444A Efferverscent tablets containing troxerutin and their preparation |
| 05/11/2005 | CN1613443A Emodin application for preparaing medicine with nervous centralis erethism inhibition |
| 05/11/2005 | CN1201005C Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/11/2005 | CN1200951C Process for productio nof multiple cross-linked hyaluronic acid derivatives |
| 05/11/2005 | CN1200945C Process for acylation of amino alcohols |
| 05/11/2005 | CN1200941C Intermediates in cephalosporing production, intermediate and its use therein |
| 05/11/2005 | CN1200939C Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 05/11/2005 | CN1200938C Process for preparing 8-methoxy-quinolone |
| 05/11/2005 | CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 05/11/2005 | CN1200931C Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4- tetrahydrocarbazole |
| 05/11/2005 | CN1200930C New crystalline polymorphic form of 1-methyl-5-P-toluoylpyrroel-2-ac-etamidoacetic acid guaiacyl ester (MED 15) |
| 05/11/2005 | CN1200747C Low dose estrogen interupted hormone replacement therapy |
| 05/11/2005 | CN1200742C System and compositions used in perfusion applications |
| 05/11/2005 | CN1200736C Remidies for hepatitis |
| 05/11/2005 | CN1200720C Ointment for treating burn and its preparing process |
| 05/11/2005 | CN1200719C Health food capable of regulating blood lipoid and delaying senility |
| 05/11/2005 | CN1200716C Antineoplastic |
| 05/11/2005 | CN1200715C Adetphos sodium chloride injection and its preparation method |
| 05/11/2005 | CN1200714C Use of diterpenoid triepoxides as anti-proliferative agent |
| 05/11/2005 | CN1200713C New (aminopropyl) methylphosphinic acids |
| 05/11/2005 | CN1200712C Combination comprising camptothecin and stilbene derivative for treatment of cancer |
| 05/11/2005 | CN1200711C Nicotine delivery system |
| 05/11/2005 | CN1200710C New use of macrolide compound |
| 05/11/2005 | CN1200709C Dextromethorphan hydrobromide drop pills and preparation process thereof |
| 05/11/2005 | CN1200708C Application of tetracyclic coumarin compounds in preparing anti-HIV medicine |
| 05/11/2005 | CN1200707C New use of taxoid derivatives |
| 05/11/2005 | CN1200706C Compositions and methods for treating or preventing inflammatory diseases |
| 05/11/2005 | CN1200705C Use of dicaffeoylquinic acid derivative and analogs in treating disease related to coronavirus infection |
| 05/11/2005 | CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease |
| 05/11/2005 | CN1200703C Use of pentanoate derivant |
| 05/11/2005 | CN1200702C Use of NMDA antagonist for treatment of irritable bowel syndrome |
| 05/11/2005 | CN1200701C Compositions for reducing incidence of necrotizing enterocolitis |
| 05/11/2005 | CN1200700C Pharmaceutical tramadol salts |